News

The acquisition is expected to expand OPKO’s business in Chile and Mexico in addition to obtaining permission for commercialization of OPKO 4KScore prostate cancer test in Brazil. OPKO

The recalled lot of the product was distributed to wholesalers, hospital and retail pharmacies in the US, Canada and Europe. The hypertonic, clear and colorless solution that has

The approval was based on positive data from liver transplant study that compared Zortress in combination with reduced-exposure tacrolimus to standard tacrolimus. Zortress, which is cleared for use

Under the collaboration, NWS will deploy eClinical OS to collect, manage and report on clinical trials data across all phases. Using a single, easy-to-use interface, eClinical OS provides

IQISH technology, based on Dako’s fast IQISH hybridization buffer chemistry, reduces the evaluation time from two days to three and a half hours, facilitating quick initiation of the

The study observed a statistically significant relationship between injected dose and antitumor activity of the investigational agent. ATLAB medical affairs head Pr. Jean-François Chatal said, "ATL101 shows a

According to the deal, Heptares will produce stabilized receptors (StaRs) for MorphoSys proposed GPCR disease target set. The Ylanthia antibody library will then be applied by MorphoSys to

Tresiba is the new once-daily basal insulin with an ultra-long duration of action for the treatment of type 1 and type 2 diabetes. Tresiba successfully achieved equivalent reductions

Coyote is expected to file IND application for CNS-102 for amyotrophic lateral sclerosis (ALS) therapy in the fourth quarter of 2013 and commence a Phase 1 study in